In this webinar, there were case study presentations from three top sarcoma institutions that demonstrate the value of biomarker testing. A Question & Answer session followed the presentations.
Here are some #GISTWishes from our LRG Community shared in our December 2021 newsletter.
Chuck Korte presented his story as Long-term GIST Survivor at New Horizons 2021.
Dr. Jonathan Noujaim and Dr. Yoon-Koo Kang presented an update to "Current GIST Treatments" at New Horizons 2021.
Sarah McGoram, Carolina Goič, Florence Thwagi, Tania Carolina Diaz presented Best Practices: How to Advocate for Better Access at New Horizons 2021.
Dr. David Josephy and Jim Hughes presented "Clinical Trials 2000-2021" at New Horizons 2021.
Pete Knox of The Life Raft Group presented Using Real World Evidence to Impact Future Clinical Trials and Improve Patient Survival: A Focus on Placebos at New Horizons 2021.
Dr. George Demetri of the Dana-Farber Cancer Institute presented “In the Beginning…The Story of How GIST Treatments Began”.
Giora Sharf and Norman Scherzer presented "Lessons Learned from the GIST & CML Community" at New Horizons 2021.
Dr. Sameer Rastogi and Dr. Yoon-Koo Kang presented "Global Access to Treatment" at New Horizons 2021.
